Two Sigma Advisers
WVE icon

Two Sigma Advisers’s Wave Life Sciences WVE Stock Holding History

Two Sigma Advisers’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-251,700
Closed -$1.84M – 2654
2025
Q3 		$1.84M Buy
251,700
+159,400
+173% +$1.29M ﹤0.01% 1171
2025
Q2 		$600K Buy
92,300
+62,700
+212% +$414K ﹤0.01% 1670
2025
Q1 		$239K Sell
29,600
-38,500
-57% -$421K ﹤0.01% 2069
2024
Q4 		$842K Buy
+68,100
New +$909K ﹤0.01% 1549
2024
Q3 		– Sell
-28,700
Closed -$143K – 2552
2024
Q2 		$143K Sell
28,700
-57,400
-67% -$327K ﹤0.01% 2274
2024
Q1 		$531K Buy
+86,100
New +$431K ﹤0.01% 1849
2021
Q4 		– Sell
-11,300
Closed -$55K – 2825
2021
Q3 		$55K Sell
11,300
-11,700
-51% -$70.9K ﹤0.01% 2366
2021
Q2 		$153K Sell
23,000
-13,300
-37% -$86.9K ﹤0.01% 2303
2021
Q1 		$204K Sell
36,300
-5,000
-12% -$48K ﹤0.01% 2352
2020
Q4 		$325K Buy
+41,300
New +$347K ﹤0.01% 2020

Other funds holding WVE

GP
GSK plc London $599M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Two Sigma Advisers's WVE Position: Q4 2025 in Review

Two Sigma Advisers sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 251,700 shares — an estimated $1.84M sold.

Two Sigma Advisers first reported a position in WVE in Q4 2020 and held it in 10 quarters. The position peaked at $1.84M in Q3 2025. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • Two Sigma Advisers reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 251,700 Wave Life Sciences shares in Q4 2025, an estimated $1.84M.
  • Two Sigma Advisers first reported a position in Wave Life Sciences in Q4 2020 and held it in 10 quarters.
  • Two Sigma Advisers's Wave Life Sciences position peaked at $1.84M in Q3 2025.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.